Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
All participants must meet these basic requirements:
- You must be willing to give your informed consent and sign a consent form
- You must be covered by a health insurance plan
Group 1 – People with adenomyosis (a condition affecting the uterus):
- You are female, aged between 28 and 57 years old
- You have not yet reached menopause
- Your doctor has recommended a full hysterectomy (removal of the uterus, keeping the ovaries) for a non-cancer reason
- You have been diagnosed with adenomyosis
Group 2 – People without adenomyosis but with another uterine condition:
- You are female, aged between 28 and 57 years old
- You have not yet reached menopause
- Your doctor has recommended a full hysterectomy (removal of the uterus, keeping the ovaries) for a non-cancer reason
- You have a functional uterine condition other than adenomyosis
Group 3 – Control group (people attending a fertility clinic):
- You are female, aged between 18 and 57 years old
- You have no symptoms such as heavy/irregular bleeding or pelvic pain
- You are being seen at the fertility clinic at Nîmes University Hospital for male-factor or unexplained infertility
- You are due to have an internal ultrasound (a scan using a small probe placed inside the vagina) as part of your fertility care
- Your uterus appears normal on that ultrasound
Who may not be able to join:
All groups:
- You have a history of an autoinflammatory or autoimmune disease (where the immune system attacks the body)
- You have a history of allergies, eczema, or asthma
- You have a history of sleep apnea (a condition where breathing stops briefly during sleep)
- You have chronic or acute kidney failure
- You have liver failure
- You have a current or past history of cancer or active tumour
- You have taken anti-inflammatory painkillers (such as ibuprofen), steroids, or aspirin in the 15 days before a specific measurement is taken in this trial
- You are currently using combined hormonal contraception (such as the combined pill or a hormonal patch)
Groups 1 and 2 only (adenomyosis groups):
- You are unable to have an MRI scan for medical reasons
Group 3 only (control group):
- You do not wish to have the internal ultrasound
- An ovarian cyst has been found on your scan or imaging (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stéphanie HUBERLANT, Centre Hospitalier Universitaire de Nīmes
Phone: 04.66.68.32.20
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of L-PGDS in vaginal swabs between groups; Concentration of L-PGDS in endometrial ablation sample in Adenomyosis - and + groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.